Digestive System Diseases
The Sleep Unit at Centro Medico Teknon-Grupo Quironsalud is investigating Crohn’s disease, focusing on the safety and tolerability of a novel subcutaneous therapy.
- Safety profiling of RO7790121 in moderate to severe Crohn’s disease
- Evaluation of patient‑reported outcomes
- Integration of endoscopic biomarkers
Three active trials involve ten investigators, advancing therapeutic options for digestive disorders.
Female Urogenital Diseases and Pregnancy Complications
Researchers are studying sleep disturbances associated with menopause and testing the efficacy of the new compound elinzanetant using polysomnography.
- Efficacy of elinzanetant on sleep architecture
- Safety monitoring in post‑menopausal women
- Quality‑of‑life assessments
The goal is to expand safe treatment choices for women experiencing menopausal sleep problems.
Nutritional and Metabolic Diseases
The site’s program includes research on obesity, evaluating the cardiovascular safety of the investigational agent BI 456906 in overweight participants.
- Cardiovascular event monitoring
- Metabolic parameter analysis
- Long‑term weight change evaluation
Findings will inform whether this therapy offers a safer approach to weight management.
